Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 725

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes

Open access
Tilley, Stephen L., Coffman, Thomas M., Koller, Beverly H. · 2001 · Journal of Clinical Investigation

Abstract

Virtually every organism has evolved mechanisms by which, upon stimulation, lipids are released from plasma membranes and metabolized into mediators capable of changing cellular physiology. As these lipids are present at the first site exposed to external challenge, they provide an ideal substrate for the synthesis of defensive mediators and homeostatic regulators. One such group of lipid mediators is the prostanoids, including the prostaglandins (PGs) and thromboxanes (TXs). Soon after their initial isolation and characterization, the ability of prostanoids to influence inflammation and immune responses was recognized. For example, administration of prostanoids, either alone or in combination, could reproduce the cardinal signs of inflammation. Because they could induce inflammatory changes when injected into tissue and were present at high levels in inflamed lesions, prostanoids were initially categorized as proinflammatory mediators. As our understanding of prostanoid physiology has evolved, it has become clear that these mediators can act to both promote and inhibit inflammation. Thus, it is more accurate to envision these molecules as part of a complex regulatory network that modulates the actions of immune cells and the surrounding microenvironment. Their overall impact in an individual inflammatory response will depend on several factors, including the level of immune cell activation, the presence of other mediators, and the physiological state of the organism. Our ability to dissect the role of prostanoids in complex inflammatory responses has been substantially advanced by the recent development of mouse lines with targeted mutations of genes encoding enzymes and receptors in the prostanoid pathway. In this review we will develop the concept that prostanoids are both effectors and regulators of inflammation, emphasizing new information provided by these mouse models.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci13416

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 10

  1. Nishigaki, 1996, Mol Pharmacol, 50, 1031
  2. 10.1084/jem.180.5.1967 · doi:10.1084/jem.180.5.1967
  3. Ruiz, 1992, Transplantation, 54, 498, 10.1097/00007890-199209000-00021 · doi:10.1097/00007890-199209000-00021
  4. Kaur, 1999, Adv Exp Med Biol, 469, 409, 10.1007/978-1-4615-4793-8_59 · doi:10.1007/978-1-4615-4793-8_59
  5. Khan, 1995, Adv Exp Med Biol, 383, 35, 10.1007/978-1-4615-1891-4_5 · doi:10.1007/978-1-4615-1891-4_5
  6. 10.1172/JCI200113455 · DOI
  7. Audoly, 1999, Am J Physiol, 277, H924
  8. Hitchcock, 1978, J Pharmacol Exp Ther, 207, 630
  9. 10.1021/bi00016a035 · doi:10.1021/bi00016a035
  10. 10.1002/1529-0131(200012)43:12<2687::AID-ANR8>3.0.CO;2-9 · doi:10.1002/1529-0131(200012)43:12<2687::aid-anr8>3.0.co;2-9

Cited by

See all 725

Metadata

Authors
Tilley, S. L., Coffman, T. M., & Koller, B. H.
Venue
Journal of Clinical Investigation
Published
2001-07-01
Volume
108
Issue
1
Pages
15-23
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2028089693
Cited by
725
References
44
FWCI
24.76
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.